EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Emerging biomarkers in cardiovascular disease

Zeeshan Ahmed

Advances in Clinical Chemistry · 2026

DOI: 10.1016/bs.acc.2026.08.004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advances in Clinical Chemistry, 2026. Verfasst von Zeeshan Ahmed. Beteiligte Einrichtung: Department of Medicine, Division of Cardiovascular Diseases and Hypertension, Robert Wood Johnson Medical School, and Rutgers Institute for Health, H…. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Biomarkers. Die Arbeit nennt 71 Literaturangaben. Gefördert von: School of Medicine, University of Connecticut.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular disease (CVD) is among the leading causes of morbidity and mortality worldwide. Advances in the development of novel diagnostic and therapeutic strategies are required to improve diagnostic accuracy and provide personalized treatments in CVD. Emerging research substantiates the role of genetic composition in CVD, prompting more comprehensive understanding via multimodal approaches that integrate clinical, genomic, and transcriptomic data. Traditional bioinformatics and statistical modelling have long been defaults for the analysis and interpretation of single-omic and clinical data. Implementation of reproducible, replicable, and transparent artificial intelligence (AI) and machine learning (ML) has the potential to revolutionize the investigation of high dimensionality and heterogeneity of multimodal data. As such, AI/ML can be helpful in discovering novel biomarkers and predicting disease susceptibility in general and CVD specifically. Herein, this review compares and discusses results produced using orthodox bioinformatics and statistics vs AI/ML methodology investigating whole genome, transcriptome and clinical data in CVD. Advances include emerging biomarkers associated with CVD (heart failure, atrial fibrillation, atherosclerosis, cardiomyopathy), others (multiple cancer disorders, anemia, type 1 diabetes mellitus, periodontal and rare diseases) and those common to both.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesBiomarkersHumansArtificial IntelligenceMachine LearningComputational BiologyGenomicsMultiomics

Stichwörter der Autor:innen

Artificial intelligenceBiomarkersCardiovascular diseasesGenomicsMachine learningMulti-omicsTranscriptomics

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Medicine, Division of Cardiovascular Diseases and Hypertension, Robert Wood Johnson Medical School, and Rutgers Institute for Health, Health Care Policy and Aging Research, Rutgers, The State University of…

Förderung

  • School of Medicine, University of Connecticut

Zitieren

APA

Ahmed, Z. (2026). Emerging biomarkers in cardiovascular disease. Advances in Clinical Chemistry. https://doi.org/10.1016/bs.acc.2026.08.004

Vancouver

Ahmed Z. Emerging biomarkers in cardiovascular disease. Advances in Clinical Chemistry. 2026. doi:10.1016/bs.acc.2026.08.004

BibTeX
@article{Ahmed2026,
  author = {Ahmed, Zeeshan},
  title = {Emerging biomarkers in cardiovascular disease},
  journal = {Advances in Clinical Chemistry},
  year = {2026},
  doi = {10.1016/bs.acc.2026.08.004}
}
Kostenlos starten →